X4 Pharmaceuticals Inc (NASDAQ:XFOR)
| 0.83 Delayed Data As of Mar 24 |  -0.01 / -1.19%Today’s Change | 0.65 Today|||52-Week Range 2.41 | -16.41% Year-to-Date |
Latest XFOR News | Press Releases
No recent news for X4 Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.84 |
| Today’s open | 0.83 |
| Day’s range | 0.83 - 0.85 |
| Volume | 15,023 |
| Average volume (3 months) | 1,117,964 |
| Market cap | $105.9M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -28.81% |
| Earnings growth (this year) | +64.54% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VXRTVaxart Inc | +0.01 | +1.04% |
| XBITXBiotech Inc | +0.05 | +1.54% |
| ---- | ||
| DRIODarioHealth Corp | -0.04 | -0.98% |
Data as of 3:59pm ET, 03/24/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$88.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
